The hemoadsorption approach was implemented another three times over a 5-day period, and the patient’s condition gradually improved. On the 13th day, decreased levels of IL-10 (30.06 pg/ml) and IFN-γ (50.69 pg/ml) (Fig1), improvement of liver function (ALT 257 U/L, AST 393 U/L, TBIL 79.91 umol/L, Fib 1.45 g/l), and increased platelet counts were evident. She was discharged on day 40 after admission due to her good recovery status. The patient underwent an additional 30 days of chemotherapeutic treatment, and no disease recurrence was evident as of eight months post-discharge.